Detalles de la búsqueda
1.
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study.
Lancet Oncol
; 24(1): 33-44, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36460017
2.
Masticatory efficiency in complete denture and single implant-retained mandibular overdenture wearers with different occlusion schemes: A randomized clinical trial.
J Prosthet Dent
; 129(6): 888-894, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34517991
3.
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 395(10240): 1835-1844, 2020 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32534646
4.
Superoxide dismutase activity in adriamycin-induced cardiotoxicity in humans: a potential novel tool for risk stratification.
J Card Fail
; 11(3): 220-6, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15812751
Resultados
1 -
4
de 4
1
Próxima >
>>